Built for the Journey: The Value of Active ULD Containers in Pharma Air Freight
Every pharma air freight shipment passes through a series of hands. A warehouse team prepares it. A ground handler team transfers it. An airline flies it. Customs clears it. A carrier team delivers it. Along the way, the product inside the container experiences multiple modes of transport and transfers with potential delays, where one party’s […]
Complete Toolset. Connected Intelligence. Confident Decisions.
Complete Toolset. Connected Intelligence. Confident Decisions. In today’s pharmaceutical supply chain, visibility alone is no longer enough.Organizations need connected systems, reliable data, and actionable insights to ensure compliance, and deliver life-enhancing products.. CSafe delivers the industry’s most complete digital and data ecosystem—combining advanced monitoring devices, connected containers, powerful analytics , and dependable services to provide […]
Building a More Sustainable Cold Chain Through Intelligence, Resilience, and Accountability
The global cold chain environment is more challenging — and more consequential — than ever: In this environment, sustainability is not a standalone initiative. It is the result of smarter, more resilient decisions—about how shipments are planned, protected, and executed across every handoff. Start with What Matters Most: Get It Right the First Time One […]
Scaling Cell and Gene Therapy Logistics
For CGTs to reach their full potential and achieve global accessibility, scalable logistics systems are vital. This article delves into the challenges and innovative solutions shaping the scalability of CGT logistics.
Elevating Cell and Gene Therapy Logistics: 7 ways CSafe adds value outside the box
This article highlights seven key ways CSafe adds value outside the box across the pharmaceutical product life cycle.
Rethinking logistics, the key barrier to scaling cell and gene therapies
This article discusses the critical role that logistics play in enabling patients to gain access to cell and gene therapies, and the steps pharma companies must take to scale up breakthrough discoveries to a viable commercial product offering.